BioNTech's Ozlem Tureci says the know-how behind revolutionary inoculations could soon be used to treat far more than the coronavirus pandemic

ICRF hopes new donations, at $4.3 million, will encourage the Jewish state to continue to serve as 'a major source of innovation'